IP Library Granted Patent US 10,960,145
Granted Patent B2
US 10,960,145 · App. 16/055,863 · Granted Mar 30, 2021

Drug delivery device

Inventors: Michael Harms (Frankfurt am Main, DE); Verena Hofmann (Frankfurt am Main, DE); Gareth Roberts (Wrexham, GB); Chris Ward (Prestatyn, GB); Graham Wilson (Flintshire, GB)
Assignee: Sanofi-Aventis Deutschland GMBH
A61M5/3271A61M5/3135A61M5/326A61M5/3232A61M5/3245A61M5/3257A61M5/3272A61M5/3287A61M5/3204A61M5/46A61M2005/3247A61M2005/3267A61M2205/582A61M2205/583A61M2205/586
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,960,145
App. No.
16/055,863
Granted
Mar 30, 2021
Kind
B2
Abstract

A drug delivery device for setting and dispensing a dose of a drug is presented having a support body having a first end defining a first opening and a second end defining a second opening and a centered outer indicator ring. A syringe barrel sealed by a stopper is slidably diposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly, wherein the syringe barrel is positioned within the support body. A needle shield is adapted to be coupled to one of the ends of the support body and slidably disposed thereon. An outer body is adapted to be coupled to the other end of the support body and slidably disposed thereon, wherein the outer indicator ring limits the movement of the outer body as well as of the needle shield.

Claims (30)

1. A drug delivery device comprising:

a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly;

a needle shield configured to be coupled to the support body and slidably disposed thereon, the needle shield comprising a direction indicator; and

an outer body configured to be coupled to the support body,

wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

2. The drug delivery device of claim 1 , wherein the needle shield comprises a mating surface to couple to the support body.

3. The drug delivery device of claim 1 , further comprising a detent mechanism configured to constrain movement of the needle shield relative to the support body by opposing the movement with a detent force.

4. The drug delivery device of claim 3 , wherein the detent mechanism comprises at least one guiding track defined on the support body and at least one retaining clip on the needle shield deflectable by the at least one guiding track, wherein the at least one guiding track is configured such that the retaining clip follows a first path when the needle shield is depressed for needle extension and a different second path when the needle shield is subsequently extended, wherein a non-return catch is arranged for catching the retaining clip at an end of the second path.

5. The drug delivery device of claim 1 , wherein the support body comprises a guiding slot disposed within a wall of the support body, the guiding slot configured to guide movement of the needle shield.

6. The drug delivery device of claim 1 , wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

7. The drug delivery device of claim 1 , wherein the needle shield comprises a body section and a cap section, the cap section of the needle shield being rotationally locked to the body section of the needle shield.

8. The drug delivery device of claim 7 , wherein the cap section of the needle shield comprises a non-circular cross section configured to engage in a corresponding opening in the body section of the needle shield.

9. A drug delivery device comprising:

a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly;

a needle shield configured to be coupled to the support body and slidably disposed thereon;

a boot remover configured to remove a protective needle boot from a needle, the boot remover comprising a direction indicator; and

an outer body configured to be coupled to the support body, wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

10. The drug delivery device of claim 9 , wherein the boot remover is configured to engage the needle boot by friction or by barbs.

11. The drug delivery device of claim 9 , wherein the boot remover comprises a handle to facilitate boot removal.

12. The drug delivery device of claim 11 , wherein the needle shield comprises an opening in which the needle boot is positioned, wherein the handle extends from the opening.

13. The drug delivery device of claim 9 , wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

14. A drug delivery device comprising:

a support body having a first end defining a first opening and a second end defining a second opening, the support body configured to retain a syringe barrel sealed by a stopper slidably disposed therein along an axial direction and adapted to have an integrated needle or to be coupled with a needle assembly; and

an outer body configured to be coupled to the support body and slidably disposed thereon, the outer body comprising a direction indicator,

wherein the support body comprises a centered outer indicator ring that limits a movement of the outer body.

15. The drug delivery device of claim 14 , wherein a portion of the outer body coupled to the support body comprises a radially outwards directed flange.

16. The drug delivery device of claim 14 , wherein the direction indicator comprises a profiled cavity or concavity in a surface of the outer body.

17. The drug delivery device of claim 14 , further comprising a detent mechanism configured to constrain movement of the outer body relative to the support body by opposing the movement with a detent force.

18. The drug delivery device of claim 14 , further comprising the syringe barrel sealed by the stopper and a plunger rod coupled to the stopper, a proximal portion of the plunger rod configured to be coupled to the outer body.

19. The drug delivery device of claim 14 , wherein the direction indicator is configured to indicate a longitudinal orientation of the drug delivery device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2024
From: SANOFI-AVENTIS DEUTSCHLAND GMBH
To: AUTO INJECTION TECHNOLOGIES LLC
Reel/Frame 068937/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 26, 2018
From: HARMS, MICHAEL; HOFMANN, VERENA; ROBERTS, GARETH; WARD, CHRIS; WILSON, GRAHAM
To: SANOFI-AVENTIS DEUTSCHLAND GMBH
Reel/Frame 046969/0597 →
Cited By (1)
US 12,214,180